Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
ANIP

Market Cap: $1.6B

AI

ANI Pharmaceuticals, Inc.

ANIP

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin65.23%

EBITDA Margin26.15%

EBIT Margin17.38%

Pre-tax Margin14.57%

Net Profit Margin10.82%

Earnings Yield7.13%

Valuation Multiples

Price / Book2.49

Price / Sales1.63

Price / Earnings14.53

PEG0.01

Forward PEG1.13

EV / Sales1.60

EV / EBITDA6.12

EV / Operating Cash Flow8.26

EV / Free Cash Flow9.82

Price / Free Cash Flow10.01

Price / Operating Cash Flow7.84

Cash Flow & Capital

Free Cash Flow / Share$7.54

Operating Cash Flow / Share$8.95

Free Cash Flow Yield9.99%

Capex / Revenue3.07%

Capex / Operating Cash Flow15.85%

Capex / Depreciation0.35

Stock Compensation / Revenue4.20%

Dividend Payout Ratio0.33%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.91

Quick Ratio2.41

Cash Ratio1.27

Debt / Assets0.22

Debt / Capital0.36

Debt / Equity0.55

Long-Term Debt / Capital0.34

Debt / Market Cap20.70%

Net Debt / EBITDA-0.12

Solvency Ratio0.21

Financial Leverage2.50

Efficiency & Working Capital

Asset Turnover0.65

Fixed Asset Turnover13.36

Inventory Turnover2.38

Receivables Turnover3.56

Payables Turnover4.61

Days Sales Outstanding102.4

Days Inventory Outstanding153.59

Days Payables Outstanding79.22

Operating Cycle255.99

Cash Conversion Cycle176.77

Working Capital Turnover1.86

Returns & Quality

Return on Equity19.19%

Return on Assets7.08%

Return on Invested Capital9.26%

ROCE12.41%

Return on Tangible Assets10.78%

Operating Return on Assets10.30%

Income Quality1.75

Tax Burden0.74

Interest Burden0.84

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.57B

Invested Capital$1.13B

Working Capital$541.78M

Tangible Asset Value$84.88M

Net Current Asset Value$-71.47M

Graham Number$56.36

Graham Net-Net-$11.52

Book Value / Share$28.23

Tangible Book Value / Share$4.01

Cash / Share$17.76

Financial Health Scores

Piotroski Score7

Altman Z-Score2.58

Revenue$978.38M

EBIT$170.03M

Market Cap$1.62B

Working Capital$541.78M

Retained Earnings$31.1M

Total Assets$1.49B

Total Liabilities$896.9M